Literatura académica sobre el tema "Pharmaceutical Benefits Scheme"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Pharmaceutical Benefits Scheme".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Pharmaceutical Benefits Scheme"
Feras, Peter M. "Pharmaceutical Benefits Scheme". Medical Journal of Australia 145, n.º 8 (octubre de 1986): 427. http://dx.doi.org/10.5694/j.1326-5377.1986.tb112410.x.
Texto completoLouis, W. J., C. J. O'Callaghan, H. Krum, A. G. Mander y E. S. B. Louis. "Pharmaceutical Benefits Scheme". Medical Journal of Australia 161, n.º 2 (julio de 1994): 174. http://dx.doi.org/10.5694/j.1326-5377.1994.tb127364.x.
Texto completoSnyder, Raymond D. "The Pharmaceutical Benefits Scheme". Medical Journal of Australia 149, n.º 7 (octubre de 1988): 394. http://dx.doi.org/10.5694/j.1326-5377.1988.tb120688.x.
Texto completoWebb, John y R. G. Robinson. "The Pharmaceutical Benefits Scheme". Medical Journal of Australia 149, n.º 7 (octubre de 1988): 394. http://dx.doi.org/10.5694/j.1326-5377.1988.tb120689.x.
Texto completoColquhoun, D. M. "The Pharmaceutical Benefits Scheme". Medical Journal of Australia 149, n.º 7 (octubre de 1988): 394–95. http://dx.doi.org/10.5694/j.1326-5377.1988.tb120690.x.
Texto completoMcLean, Allan. "The Pharmaceutical Benefits Scheme". Medical Journal of Australia 149, n.º 7 (octubre de 1988): 395. http://dx.doi.org/10.5694/j.1326-5377.1988.tb120691.x.
Texto completoShaw, John. "The Pharmaceutical Benefits Scheme". Medical Journal of Australia 149, n.º 7 (octubre de 1988): 395–96. http://dx.doi.org/10.5694/j.1326-5377.1988.tb120692.x.
Texto completoMcLean, Allan. "The Pharmaceutical Benefits Scheme". Medical Journal of Australia 149, n.º 11-12 (diciembre de 1988): 716. http://dx.doi.org/10.5694/j.1326-5377.1988.tb120842.x.
Texto completoShaw, John. "The Pharmaceutical Benefits Scheme". Medical Journal of Australia 149, n.º 11-12 (diciembre de 1988): 716. http://dx.doi.org/10.5694/j.1326-5377.1988.tb120843.x.
Texto completoLouis, W. J., C. J. O'Callaghan, H. Krum, A. G. Mander y E. S. B. Louis. "Pharmaceutical Benefits Scheme (PBS)". Medical Journal of Australia 160, n.º 5 (marzo de 1994): 306–7. http://dx.doi.org/10.5694/j.1326-5377.1994.tb125843.x.
Texto completoTesis sobre el tema "Pharmaceutical Benefits Scheme"
Sweeny, Kim. "Accounting for growth in the Pharmaceutical Benefits Scheme". Thesis, full-text, 2008. https://vuir.vu.edu.au/1960/.
Texto completoSweeny, Kim. "Accounting for growth in the Pharmaceutical Benefits Scheme". full-text, 2008. http://eprints.vu.edu.au/1960/1/sweeny.pdf.
Texto completoBlanch, Bianca. "What is normal? A critical analysis of the methods quantifying prescription drug use and potential misuse in pharmaceutical claims". Thesis, The University of Sydney, 2016. http://hdl.handle.net/2123/16910.
Texto completoSchofield, Deborah y n/a. "Modelling health care expenditure : a new microsimulation approach to simulating the distributional impact of the Pharmaceutical Benefits Scheme". University of Canberra. Information Sciences & Engineering, 1999. http://erl.canberra.edu.au./public/adt-AUC20061107.171802.
Texto completoDonnelly, Neil James Public Health & Community Medicine Faculty of Medicine UNSW. "The use of interrupted time series analysis to evaluate the impact of Pharmaceutical Benefits Scheme policies on drug utilisation in Australia". Awarded by:University of New South Wales. Public Health and Community Medicine, 2005. http://handle.unsw.edu.au/1959.4/22509.
Texto completoLee, Kah Seng. "The impact of cost containment reforms to the Pharmaceutical Benefits Scheme (PBS) on prescribing volumes and expenditure in Australia: 1992-2011". Thesis, Curtin University, 2014. http://hdl.handle.net/20.500.11937/836.
Texto completoMak, Christine Suet Yee. "Evaluation of health programs: application of social cost benefit analysis in the Pharmaceutical Benefits Scheme listing of Australia". Thesis, 2005. https://vuir.vu.edu.au/15635/.
Texto completoNeville, Warwick John. "Healing the nation : access to medicines under the Pharmaceutical Benefits Scheme - the jurisprudence from history". Phd thesis, 2007. http://hdl.handle.net/1885/150188.
Texto completoLu, Christine Yi-Ju Medical Sciences Faculty of Medicine UNSW. "An examination of systems of access to important high cost medicines: a critical analysis of the nationally subsidised scheme of access to tumour necrosis factor inhibitors in Australia". 2007. http://handle.unsw.edu.au/1959.4/40579.
Texto completoSearles, Andrew. "A preliminary analysis of the pharmaceutical provisions in the Australia-United States Free Trade Agreement on prescription medicines in Australia". Thesis, 2010. http://hdl.handle.net/1959.13/44658.
Texto completoIn January 2005 Australia implemented the Australia-United States Free Trade Agreement (AUSFTA). The AUSFTA was a historic document because it laid out a closer trading association between Australia and its close ally, the United States (US). The Agreement was generally welcomed in both countries but it contained provisions that were controversial, perhaps none more so than those covering pharmaceuticals. In Australia there was deep concern over the effects of these provisions on the Pharmaceutical Benefits Scheme (PBS). A Senate Committee investigating the likely impact of the AUSFTA was apprehensive that the provisions would result in the PBS paying higher prices for some medicines. The many outcomes from the research reported in this thesis are preliminary but amongst them, three stood out. First, the AUSFTA instituted a number of small but significant changes to Australian pharmaceutical policies and processes. Some changes, around transparency and listing times, were positive while others, such as sponsor hearings before the PBAC, will probably have limited negative impact. Second, there is now a need to consider the AUSFTA commitments when Australian health policy is reassessed in the future, which will now make Australia’s regulatory processes more complex. Third, it is argued that the AUSFTA may have had input into major reforms of the Australian PBS. These reforms delivered on an outcome that had been sought by the US: a weakening of reference pricing as used by the Australian PBS. The benefit from the change to reference pricing for Australia is unclear, but the PBS is now more vulnerable to higher prices for new medicines in the future.
Libros sobre el tema "Pharmaceutical Benefits Scheme"
Office, New Zealand Audit. Department of Health: Administration of the pharmaceutical benefits scheme. Wellington, N.Z: The Office, 1992.
Buscar texto completoZealand, New. Department of Health: Administration of the pharmaceutical benefits scheme. The Office, 1992.
Buscar texto completoAustralia. Dept. of Finance. y Australian National Audit Office, eds. Joint review by the Auditor-General and the Department of Finance: Pharmaceutical benefits scheme, review of estimated savings from proposed system for eligibility checking. Canberra: Australian Govt. Pub. Service, 1991.
Buscar texto completoOlsen, Jan Abel. The healthcare delivery system: an overview. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198794837.003.0013.
Texto completoCapítulos de libros sobre el tema "Pharmaceutical Benefits Scheme"
Karanges, Emily A., Melisa J. Litchfield, Leigh Mellish y Sallie-Anne Pearson. "The Australian Pharmaceutical Benefits Scheme (PBS) Dispensing Database". En Databases for Pharmacoepidemiological Research, 255–66. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-51455-6_21.
Texto completoEpp, Joanne, Bonny Parkinson y Sally Hawse. "Health System Sustainability: The Pharmaceutical Benefits Scheme in Australia". En Industry and Higher Education, 13–44. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-0874-5_2.
Texto completoHuang, Weng-Foung y Hung-Chi Chiang. "Pharmaceutical Benefit Scheme and Cost Containment in Taiwan's National Health Insurance". En International Drug Regulatory Mechanisms, 132–49. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003063858-7.
Texto completoLöfgren, Hans y Ken Harvey. "The Pharmaceutical Benefits Scheme". En Understanding the Australian Health Care System, 71–82. Elsevier, 2009. http://dx.doi.org/10.1016/b978-0-7295-3861-9.10007-9.
Texto completoJackson, John. "Pharmaceutical Benefits Scheme (Australia)". En Encyclopedia of Clinical Pharmacy (Print), 688–91. CRC Press, 2002. http://dx.doi.org/10.1201/b13789-119.
Texto completoJackson, John K. "Pharmaceutical Benefits Scheme (Australia)". En Encyclopedia of Clinical Pharmacy, 688–91. Informa Healthcare, 2002. http://dx.doi.org/10.3109/9780824706081.118.
Texto completode Boer, Rebecca. "Reform of the pharmaceutical benefits scheme". En Analysing Health Policy, 214–24. Elsevier, 2008. http://dx.doi.org/10.1016/b978-0-7295-3843-5.50017-x.
Texto completo"A War of Attrition: the Fate of the Pharmaceutical Benefits Scheme". En The Price of Health, 209–32. Cambridge University Press, 1991. http://dx.doi.org/10.1017/cbo9780511470189.010.
Texto completoRaymond, Chris y Brett Parsons. "Chapter 9 Modelling Medicare and Pharmaceutical Benefits Scheme (PBS) Utilisation and Costs". En Modelling our Future - Population Ageing, Health and Aged Care, 197–211. Elsevier, 2007. http://dx.doi.org/10.1016/s1571-0386(06)16009-3.
Texto completoAbello, Annie y Laurie Brown. "Model 18 MediSim (Static Microsimulation Model of the Australian Pharmaceutical Benefits Scheme)". En Modelling our Future - Population Ageing, Health and Aged Care, 533–39. Elsevier, 2007. http://dx.doi.org/10.1016/s1571-0386(06)16037-8.
Texto completoActas de conferencias sobre el tema "Pharmaceutical Benefits Scheme"
Khan, Arif, Uma Srinivasan y Shahadat Uddin. "Development and exploration of polymedication network from Pharmaceutical and Medicare Benefits Scheme data". En ACSW 2019: Australasian Computer Science Week 2019. New York, NY, USA: ACM, 2019. http://dx.doi.org/10.1145/3290688.3290738.
Texto completo